Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-431364
Filing Date
2013-11-07
Accepted
2013-11-07 06:30:53
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d593062d10q.htm 10-Q 808658
2 EX-31.1 d593062dex311.htm EX-31.1 9419
3 EX-31.2 d593062dex312.htm EX-31.2 9298
4 EX-32.1 d593062dex321.htm EX-32.1 2666
5 EX-32.2 d593062dex322.htm EX-32.2 2667
  Complete submission text file 0001193125-13-431364.txt   5597527

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aveo-20130930.xml EX-101.INS 797388
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20130930.xsd EX-101.SCH 41510
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20130930_cal.xml EX-101.CAL 51481
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20130930_def.xml EX-101.DEF 269641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20130930_lab.xml EX-101.LAB 396559
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20130930_pre.xml EX-101.PRE 313948
Mailing Address 650 E. KENDALL STREET CAMBRIDGE MA 02142
Business Address 650 E. KENDALL STREET CAMBRIDGE MA 02142 6172995000
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 131198358
SIC: 2834 Pharmaceutical Preparations